JP2004531697A5 - - Google Patents

Download PDF

Info

Publication number
JP2004531697A5
JP2004531697A5 JP2002558684A JP2002558684A JP2004531697A5 JP 2004531697 A5 JP2004531697 A5 JP 2004531697A5 JP 2002558684 A JP2002558684 A JP 2002558684A JP 2002558684 A JP2002558684 A JP 2002558684A JP 2004531697 A5 JP2004531697 A5 JP 2004531697A5
Authority
JP
Japan
Prior art keywords
nogo
bace
polypeptide
modulator
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002558684A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004531697A (ja
Filing date
Publication date
Priority claimed from GBGB0101313.5A external-priority patent/GB0101313D0/en
Application filed filed Critical
Publication of JP2004531697A publication Critical patent/JP2004531697A/ja
Publication of JP2004531697A5 publication Critical patent/JP2004531697A5/ja
Pending legal-status Critical Current

Links

JP2002558684A 2001-01-18 2002-01-18 アッセイ Pending JP2004531697A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0101313.5A GB0101313D0 (en) 2001-01-18 2001-01-18 Assay
PCT/GB2002/000214 WO2002058323A2 (en) 2001-01-18 2002-01-18 Method for identifying modulators of bace

Publications (2)

Publication Number Publication Date
JP2004531697A JP2004531697A (ja) 2004-10-14
JP2004531697A5 true JP2004531697A5 (https=) 2005-12-22

Family

ID=9907053

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002558684A Pending JP2004531697A (ja) 2001-01-18 2002-01-18 アッセイ

Country Status (6)

Country Link
US (1) US20040146953A1 (https=)
EP (1) EP1352084A2 (https=)
JP (1) JP2004531697A (https=)
AU (1) AU2002225169A1 (https=)
GB (1) GB0101313D0 (https=)
WO (1) WO2002058323A2 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0101312D0 (en) 2001-01-18 2001-02-28 Glaxo Group Ltd Assay
US20060287501A1 (en) * 2002-10-31 2006-12-21 Pieris Proteolab Ag Soluble truncated polypeptides of the nogo-a protein
JP2005145837A (ja) * 2003-11-12 2005-06-09 Institute Of Physical & Chemical Research アルツハイマー病の診断方法
CA2549956C (en) * 2003-12-22 2016-04-12 Glaxo Group Limited Immunoglobulins
ES2400287T3 (es) * 2005-03-14 2013-04-08 High Point Pharmaceuticals, Llc Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ304224B6 (cs) * 1998-11-06 2014-01-15 Schwab Monoklonální protilátka
US7087399B1 (en) * 1999-05-13 2006-08-08 Scios, Inc. β-secretase and modulation of β-secretase activity
IL150566A0 (en) * 2000-01-12 2003-02-12 Univ Yale Nucleic acids and polypeptides and nogo-receptor proteins

Similar Documents

Publication Publication Date Title
Ramos-Cejudo et al. Traumatic brain injury and Alzheimer's disease: the cerebrovascular link
Chodavarapu et al. Rosiglitazone treatment of type 2 diabetic db/db mice attenuates urinary albumin and angiotensin converting enzyme 2 excretion
MX2019005415A (es) Anticuerpos de il-6 y uso de los mismos.
WO2006036744A3 (en) Methods for a global assay of coagulation and fibrinolysis
WO2006081521A3 (en) Methods for diagnosis and intervention of hepatic disorders
FR2870349A1 (fr) Methode pour diagnostiquer la presence et/ou la severite d'une pathologie hepatique chez un sujet et/ou pour suivre l'efficacite d'un traitement d'une telle pathologie
WO2008137838A3 (en) Interferon alpha-induced pharmacodynamic markers
ATE488765T1 (de) Verfahren zum frühen nachweis einer nierenkrankheit und -verletzung
Szabo et al. Matrix metalloproteinases and the immune response
DE60230320D1 (de) Diagnose von einer klinischen infektion einer wunde
Zhang et al. Sink hypothesis and therapeutic strategies for attenuating Aβ levels
JP2004531697A5 (https=)
WO2007038115A3 (en) Ppar-gamma agonists for improvement of cognitive function in apoe4 negative patients
ATE451477T1 (de) Diagnose und überwachung von hepatozellulärem karzinom
JP2014529606A5 (https=)
WO2002010357A3 (en) Gsk3 polypeptides
Kiser et al. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin‐induced thrombocytopenia
DE602005023009D1 (de) Verfahren in echtzeit zur erkennung von akuten entzündungszuständen
JP2004520041A5 (https=)
RU2005109094A (ru) Способ диагностики перинатальных гипоксических поражений головного мозга у доношенных новорожденных
Ibrahim et al. Depression among Egyptian End Stage Renal Disease Patients Under Maintenance Hemodialysis.
DE60223729D1 (de) Verbindungen zur diagnose und überwachung von erkrankungen in zusammenhang mit der bildung von amyloidfibrillen
Chan et al. Pragmatic comparison of β2-agonist side effects within the Worldwide Atosiban versus Beta Agonists study
WO2002075317A3 (en) Screening for drugs against disorders associated with schizophrenia
WO2006116688A3 (en) Mif agonists and antagonists and therapeutic uses thereof